TRIM14 and gastric cancer: (74) demonstrated in vitro and in vivo that circ_0091741 increased the expression of TRIM14 by blocking the binding of miR-330–3p to TRIM14, which activated Wnt/β-catenin by stabilizing the Dvl2 pathway to promote chemoresistance in gastric cancer cells.